Kaia Health, a digital therapeutics company focused on helping people manage chronic conditions, has closed a $26 million Series B funding round that includes investment by world No 1 Rory McIlroy.

The round was led by Optum Ventures, Idinvest and capital300 with participation from existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures (an investment partnership with McIlroy). 

McIlroy said: “Kaia’s conservative and innovative approach to pain management resonated with my early-career experience of back pain. Strengthening my core muscle groups has been central to both my success as a professional golfer and ongoing injury prevention.”